Alan Lotvin - Dec 27, 2021 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Signature
/s/ Alan M. Lotvin
Stock symbol
CVS
Transactions as of
Dec 27, 2021
Transactions value $
-$17,756
Form type
4
Date filed
12/28/2021, 04:04 PM
Previous filing
Jun 29, 2021
Next filing
Feb 2, 2022

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Phantom Stock Credits 557 Dec 27, 2021 Common Stock 557 $1.00 Direct F2, F3
holding CVS Stock Option 21.4K Dec 27, 2021 Common Stock 21.4K $102.26 Direct F4
holding CVS Stock Option 27.4K Dec 27, 2021 Common Stock 27.4K $104.82 Direct F5
holding CVS Stock Option 32.9K Dec 27, 2021 Common Stock 32.9K $78.05 Direct F6
holding CVS Stock Option 22.5K Dec 27, 2021 Common Stock 22.5K $62.21 Direct F7
holding CVS Stock Option 70.7K Dec 27, 2021 Common Stock 70.7K $54.19 Direct F8
holding CVS Stock Option 141K Dec 27, 2021 Common Stock 141K $58.34 Direct F9, F10
holding CVS Stock Option 121K Dec 27, 2021 Common Stock 121K $74.30 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible.
F2 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F6 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F9 The number of shares subject to the option were calculated using a 30-day average price.
F10 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F11 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.